What is it about?
Paediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT) develop oral mucositis grade 3 and/or 4 , requiring hospitalization for parenteral feeding . A new protocol has been proposed in order to reduce the time of hospitalization of these patients and to minimize pain and discomfort due to oral mucositis.
Featured Image
Why is it important?
In this paper we define a new protocol for oral mucositis developed after hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT) in pediatric onco-haematological patients. The application of photo-biomodulation in 4 steps showed an immediate improvement of healing in ulcerated oral mucosa, reducing patient's pain and discomfort, parenteral feeding time, total period of hospitalization .
Perspectives
The application of our protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT) could improve quality of life for these children and their families.
Professor marina consuelo vitale vitale
University of Pavia
Read the Original
This page is a summary of: Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT), Lasers in Medical Science, June 2017, Springer Science + Business Media,
DOI: 10.1007/s10103-017-2266-y.
You can read the full text:
Contributors
The following have contributed to this page
